ABOUT US

Shandong Zhushi Pharmaceutical Group Co., Ltd. was founded in 2003 with a registered capital of 500 million yuan. It has over 5000 registered employees and an annual production value of 5 billion yuan. It has built research and development, production, and marketing bases in Jinan, Shanghai, Guangdong, Tianjin, Shaanxi, Guizhou, Gansu, Hunan, Hubei, Anhui, Jiangsu, and other places. The group has invested in the construction of two modern and technological health industry parks, covering a total area of over 500 acres.

Milestones

2003

Shandong Zhushi Pharmaceutical Group was founded in December 2003.
2004

The first independent brand of Zhushi Pharmaceutical was created. Zhushi Pharmaceutical Group officially entered the stage of independent brand and OEM

coordinated development.
2006

The first branch of Zhushi Pharmaceutical Group was founded to regulate the industrial division, which aims to create a complete industrial chain and lay a solid foundation for the output of high-quality products.
2015

After the success of the first battle, the Group began to build the second phase project, and introduced a number of production lines such as food and cosmetics to create a more complete production chain. In the same year, the Group is evaluated as “key intellectual property protection enterprise” in Heze City.
2018

After the success of the first battle, the Group began to build the second phase project, and introduced a number of production lines such as food and cosmetics to create a more complete production chain. In the same year, the Group is evaluated as “key intellectual property protection enterprise” in Heze City.
2020

To optimize the R&D and innovation system, the Group established an R&D laboratory, which was listed as “Shandong Engineering Laboratory” by the provincial government, and made a major breakthrough in the application of in vitro diagnostic reagents in immunochromatography. In the same year, the American trademark registration certificate for the Group “ZS” was approved, and Zhushi Pharmaceutical Group accelerated its progress in the strategic layout of globalization.
2022

The Group was in the rising period of industrial scale, adjusted the strategic policy, re-combed the enterprise management chain, optimized the enterprise business chain, and announced to enter the comprehensive fine production. Simultaneously, the Group held the hot-selling product release conference themed on “era of hot-selling product, and layout for the future”, and comprehensively changed to the direction of independent intellectual property product production and independent brand creating.

ABOUT US

Milestones

2003

2004

2006

2015

2018

2020

2022